Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy.
作者信息
Maron B J
出版信息
Heart. 2003 Sep;89(9):977-8. doi: 10.1136/heart.89.9.977.
Abstract
摘要
相似文献
1
Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy.肥厚型心肌病风险分层、猝死及预防的当代考量
Heart. 2003 Sep;89(9):977-8. doi: 10.1136/heart.89.9.977.
2
Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.肥厚型心肌病与猝死：植入式心脏复律除颤器在风险分层与预防方面的新视角
Eur Heart J. 2000 Dec;21(24):1979-83. doi: 10.1053/euhj.2000.2238.
3
Prevention of sudden cardiac death in hypertrophic cardiomyopathy.肥厚型心肌病心脏性猝死的预防
Heart. 2014 Feb;100(3):254-60. doi: 10.1136/heartjnl-2012-301996. Epub 2013 Apr 10.
4
Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?肥厚型心肌病、猝死与植入式心脏除颤器：标准能有多低？
JAMA. 2007 Jul 25;298(4):452-4. doi: 10.1001/jama.298.4.452.
5
Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者心脏性猝死风险评估中的跨大西洋差异。
Int J Cardiol. 2015;186:3-4. doi: 10.1016/j.ijcard.2015.03.207. Epub 2015 Mar 18.
6
[Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].[2016年肥厚型心肌病猝死的风险分层]
Presse Med. 2016 Oct;45(10):903-910. doi: 10.1016/j.lpm.2016.04.011. Epub 2016 May 24.
7
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器对肥厚型心肌病患者预防猝死的疗效。
N Engl J Med. 2000 Feb 10;342(6):365-73. doi: 10.1056/NEJM200002103420601.
8
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.作为肥厚型心肌病的一种新型治疗策略的心脏性猝死一级预防。
Circulation. 2003 Jun 17;107(23):2872-5. doi: 10.1161/01.CIR.0000072343.81530.75.
9
Risk stratification in hypertrophic cardiomyopathy: fact or fiction?肥厚型心肌病的风险分层：事实还是虚构？
J Am Coll Cardiol. 2003 Sep 3;42(5):880-1. doi: 10.1016/s0735-1097(03)00838-6.
10
[Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].[植入式除颤器在肥厚型心肌病猝死预防中的应用]
Tunis Med. 2003;81 Suppl 8:675-9.
引用本文的文献
1
Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.超声心动图作为肥厚型心肌病患儿心肌瘢痕的筛查试验
Int J Pediatr. 2016;2016:1980636. doi: 10.1155/2016/1980636. Epub 2016 Nov 15.
2
Sudden cardiac arrest in apical hypertrophic cardiomyopathy.肥厚型心肌病心尖部病变引发的心脏骤停
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.04.2009.1753. Epub 2009 Sep 6.
3
ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy.ESCAPE-HCM 研究：肥厚型心肌病无症状患者筛查评估。
Neth Heart J. 2007;15(6):216-20. doi: 10.1007/BF03085983.
4
Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.肥厚型心肌病中心律失常的影响及猝死的预防
Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. doi: 10.1111/j.1542-474X.2007.00157.x.
5
Sudden cardiac death in athletes.运动员心源性猝死
Curr Cardiol Rep. 2006 Sep;8(5):316-22. doi: 10.1007/s11886-006-0069-z.
本文引用的文献
1
Asymmetrical hypertrophy of the heart in young adults.年轻成年人心脏不对称性肥大。
Br Heart J. 1958 Jan;20(1):1-8. doi: 10.1136/hrt.20.1.1.
2
Heart rate variability in children with hypertrophic cardiomyopathy.肥厚型心肌病患儿的心率变异性
Heart. 2003 Feb;89(2):205-6. doi: 10.1136/heart.89.2.205.
3
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.肥厚型心肌病中β-肌球蛋白重链和肌钙蛋白T基因恶性突变的患病率及年龄依赖性：一项综合门诊视角的研究
J Am Coll Cardiol. 2002 Jun 19;39(12):2042-8. doi: 10.1016/s0735-1097(02)01900-9.
4
Hypertrophic cardiomyopathy: a systematic review.肥厚型心肌病：一项系统综述。
JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308.
5
Task Force on Sudden Cardiac Death of the European Society of Cardiology.欧洲心脏病学会心脏性猝死特别工作组
Eur Heart J. 2001 Aug;22(16):1374-450. doi: 10.1053/euhj.2001.2824.
6
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者左心室肥厚严重程度与预后的关系。
Lancet. 2001 Feb 10;357(9254):420-4. doi: 10.1016/S0140-6736(00)04005-8.
7
Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort.
Am J Cardiol. 2001 Jan 1;87(1):114-5, A9. doi: 10.1016/s0002-9149(00)01285-6.
8
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.肥厚型心肌病猝死：高危患者的识别
J Am Coll Cardiol. 2000 Dec;36(7):2212-8. doi: 10.1016/s0735-1097(00)01003-2.
9
The utilization of the implantable defibrillator--a European enigma.植入式除颤器的应用——一个欧洲谜团。
Eur Heart J. 2000 Dec;21(24):1998-2004. doi: 10.1053/euhj.2000.2473.
10
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.肥厚型心肌病相关死亡的流行病学：在一个大型非转诊患者群体中的重新审视
Circulation. 2000 Aug 22;102(8):858-64. doi: 10.1161/01.cir.102.8.858.
Zotero 插件